Cleared Traditional

K052825 - VISULIZE FACTOR VIII ANTIGEN KIT, MODEL FVIII-AG
(FDA 510(k) Clearance)

Jan 2006
Decision
107d
Days
Class 2
Risk

K052825 is an FDA 510(k) clearance for the VISULIZE FACTOR VIII ANTIGEN KIT, MODEL FVIII-AG. This device is classified as a Test, Qualitative And Quantitative Factor Deficiency (Class II - Special Controls, product code GGP).

Submitted by Affinity Biologicals, Inc. (Ancaster, Ontario, CA). The FDA issued a Cleared decision on January 20, 2006, 107 days after receiving the submission on October 5, 2005.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7290.

Submission Details

510(k) Number K052825 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 2005
Decision Date January 20, 2006
Days to Decision 107 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGP — Test, Qualitative And Quantitative Factor Deficiency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7290

Similar Devices — GGP Test, Qualitative And Quantitative Factor Deficiency

All 189
CRYOcheck Chromogenic Factor VIII
K251440 · Precision Biologic, Inc. · Aug 2025
HemosIL Chromogenic Factor IX
K230852 · Instrumentation Laboratory Company · Dec 2023
vWF Ag
K220728 · Siemens Healthcare Diagnostics Products GmbH · Jun 2023
CRYOcheck Chromogenic Factor IX
K214002 · Precision Biologic, Inc. · Dec 2022
HemosIL von Willebrand Factor Antigen
K223402 · Instrumentation Laboratory CO · Dec 2022
HemosIL von Willebrand Factor Antigen
K200033 · Instrumentation Laboratory CO · Aug 2020